Skip to main content
TipRanks
Go Ultimate75% OFF

Arvee Laboratories (India) Ltd. (ARVEE) AI Stock Analysis

0 Followers
IN:ARVEE

Arvee Laboratories (India) Ltd.

(NSE:ARVEE)

Select Model
Rating:64Neutral
Price Target:INR 222.00â–²(8.02% Upside)
Action:reiterated
Date:09/29/26

Arvee Laboratories earns a moderate overall score driven by exceptionally strong technical momentum and a fortress balance sheet with minimal debt. However, the premium valuation, volatile revenue profile, and persistent cash flow deficits act as significant constraints, requiring investor caution despite the recent positive price action.

Positive Factors
Very low leverageVery low leverage and steadily growing equity reduce financial risk and preserve flexibility. A stronger balance sheet gives Arvee greater capacity to withstand weaker demand, support operations, and fund future opportunities without relying heavily on external borrowing.
Negative Factors
Volatile revenue trendSharp revenue reversals point to unstable demand or pricing and make future growth less predictable. Continued sales contraction could reduce operating leverage, weaken reinvestment capacity, and pressure earnings quality even while the company remains profitable.

Arvee Laboratories (India) Ltd. (ARVEE) vs. iShares MSCI India ETF (INDA)

-20%0%20%40%60%80%IN:ARVEE+23.84%INDA-5.96%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
INR 2.32B
Dividend Yield
―
Average Volume (3M)
16.02K
Price to Earnings (P/E)
34.3
Beta (1Y)
1.36
Revenue Growth
138.64%
EPS Growth
1536.16%
Country
India
Employees
57
Sector
Basic Materials
Sector Strength
61
Industry
Chemicals - Specialty

Arvee Laboratories (India) Ltd. Business Overview & Revenue Model

Company Description

Arvee Laboratories (India) Ltd., established in 2012 and headquartered in Ahmedabad, India, specializes in the production and distribution of various specialized chemicals throughout the country. The company's product line includes a range of polymer...

Arvee Laboratories (India) Ltd. Financial Statement Overview

Summary

Arvee Laboratories displays a pristine, unlevered balance sheet and improving profit margins. However, top-line volatility and consecutive years of severe free cash flow deficits significantly weigh on the overall financial profile.

Income Statement

55Neutral

Balance Sheet

85Very Positive

Cash Flow

30Negative
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue627.37M315.14M384.87M303.42M612.76M471.44M
Gross Profit183.33M111.68M121.63M41.49M173.09M142.99M
EBITDA86.53M31.98M42.69M30.46M86.34M61.30M
Net Income65.97M25.26M21.47M10.52M41.19M26.77M
Balance Sheet
Total Assets611.88M432.57M381.58M381.99M386.85M410.46M
Cash, Cash Equivalents and Short-Term Investments129.31M32.82M49.06M18.65M8.92M86.39M
Total Debt10.00M11.13M10.33M10.00M10.00M88.79M
Total Liabilities231.50M95.30M68.97M90.85M106.23M196.08M
Stockholders Equity380.38M337.88M312.61M291.14M280.62M214.38M
Cash Flow
Free Cash Flow0-29.02M-17.35M10.78M14.45M-5.80M
Operating Cash Flow0-694.00K1.19M36.64M29.29M17.11M
Investing Cash Flow02.17M-17.91M-21.63M-12.58M-6.04M
Financing Cash Flow0802.00K333.00K-1.88M-24.17M45.20M

Arvee Laboratories (India) Ltd. Technical Analysis

Technical Analysis SentimentNeutral
Last Price205.52

Price Trends

50DMA206.01Negative
100DMA184.49Positive
200DMA171.98Positive

Market Momentum

MACD3.39Positive
RSI47.07Neutral
STOCH19.50Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ARVEE, the sentiment is Neutral. The current price of 205.52 is below the 20-day moving average (MA) of 207.31, below the 50-day MA of 206.01, and above the 200-day MA of 171.98, indicating a neutral trend. The MACD of 3.39 indicates Positive momentum. The RSI at 47.07 is Neutral, neither overbought nor oversold. The STOCH value of 19.50 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:ARVEE.

Arvee Laboratories (India) Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

IN:ARVEE against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:TAINWALCHMIN:TAINWALCHM64NeutralINR 1.87B23.74―1.53%-17.16%3.36%
IN:ARVEEIN:ARVEE64NeutralINR 2.26B34.31――138.64%1536.16%
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
IN:PODDARMENTIN:PODDARMENT57NeutralINR 2.63B17.60―1.62%4.50%-17.13%
IN:SRDIN:SRD54NeutralINR 3.04B12.78―0.11%19.82%92.88%
IN:AKSHARCHEMIN:AKSHARCHEM50NeutralINR 2.74B9.24―0.14%32.59%1397.90%
IN:VINEETLABIN:VINEETLAB47NeutralINR 726.00M15.39――3.64%―

* Basic Materials Sector Average

Performance Comparison

0%50%IN:ARVEEIN:AKSHARCHEMIN:PODDARMENTIN:SRDIN:TAINWALCHMIN:VINEETLABDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IN:ARVEE and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:ARVEEArvee Laboratories (India) Ltd.205.5239.5723.84%
IN:AKSHARCHEMAksharChem India Ltd.340.9592.6537.31%
IN:PODDARMENTPoddar Pigments Limited246.95-12.84-4.94%
IN:SRDShankar Lal Rampal Dye-Chem Ltd.46.11-19.45-29.66%
IN:TAINWALCHMTainwala Chemicals & Plastics (India) Ltd193.600.570.29%
IN:VINEETLABVineet Laboratories Ltd.37.802.426.84%

Arvee Laboratories (India) Ltd. Corporate Events

Arvee Laboratories Fined by NSE for Technical SEBI Compliance Lapse

Oct 15, 2026

Arvee Laboratories (India) Ltd. operates in the chemicals and laboratory products sector from its base in Ahmedabad and is listed on the National Stock Exchange under the symbol ARVEE. The company functions within SEBI’s stringent listing and disclos...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 29, 2026